CD8A and neoplasm: The immunohistochemistry imaging and statistical data also provided visible evidences that the percentage of CD8+ positive staining cells in the tumor sections treated by E7 + RT (16.5%) was much higher than the other three treatments (Fig. 4d and Supplementary Fig. 7).